ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Bioadaptives Inc (PK)

Bioadaptives Inc (PK) (BDPT)

0.0005
0.00
( 0.00% )
Updated: 06:37:23

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.0005
Bid
0.0004
Ask
0.0005
Volume
-
0.00 Day's Range 0.00
0.0003 52 Week Range 0.006
Previous Close
0.0005
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
13,446,482
Financial Volume
-
VWAP
-

BDPT Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0001250.00040.00050.00049740240.0005CS
4-0.0001-16.66666666670.00060.00060.000440635220.00048478CS
12000.00050.00080.0004134464820.00055671CS
26000.00050.00140.0003263306510.0006349CS
52-0.0011-68.750.00160.0060.0003292029600.00122628CS
156-0.0374-98.68073878630.03790.0490.00025165174580.00137575CS
260-0.1784-99.72051425380.17890.1870650.00025106448360.00153254CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MIRAMIRA Pharmaceuticals Inc
$ 1.7097
(148.21%)
63.01M
CMAXCareMax Inc
$ 2.9286
(85.35%)
2.91M
SERVServe Robotics Inc
$ 13.43
(77.88%)
66.24M
RRRichtech Robotics Inc
$ 2.05
(39.46%)
55.01M
SAVACassava Sciences Inc
$ 12.93
(28.27%)
3.89M
LGCBLinkage Global Inc
$ 3.795
(-27.23%)
60.04k
HEPAHepion Pharmaceuticals Inc
$ 0.7695
(-24.56%)
6.33M
PSIGPS International Group Ltd
$ 2.66
(-21.99%)
124.7k
XCURExicure Inc
$ 0.4301
(-19.62%)
1.29M
LOBOLOBO EV Technologies Ltd
$ 2.00
(-19.47%)
2.32k
NCPLNetcapital Inc
$ 0.1321
(27.02%)
84.64M
SERVServe Robotics Inc
$ 13.43
(77.88%)
66.24M
MIRAMIRA Pharmaceuticals Inc
$ 1.7097
(148.21%)
63.01M
NVDANVIDIA Corporation
$ 121.80
(3.28%)
57.34M
RRRichtech Robotics Inc
$ 2.05
(39.46%)
55.01M

BDPT Discussion

View Posts
mars2063 mars2063 4 days ago
Pdg ?? News??? 0x0 =00000 !!!!
๐Ÿ‘๏ธ0
DK11 DK11 2 weeks ago
Why would anyone take over this stock unless they have a plan?
๐Ÿ‘๏ธ0
carusso carusso 3 weeks ago
The new CEO buying a bunch of stock would be a bright ideaโ€ฆ
๐Ÿ‘๏ธ0
carusso carusso 3 weeks ago
Re:โ€Maybe the new CEO will have some bright idea like mailing out product catalogs like good ole Sears. This new fandangled online purchasing like Amazon is just a fad........โ€

What are you ON, Man?
๐Ÿ‘๏ธ0
LJ-Bodhi LJ-Bodhi 4 weeks ago
The company has 1,231,718,974 OS with a 1.25b AS. They publicly disclose they have minimal revenues and intend to raise money by offering more shares. The next significant news beyond some fluff product news release will likely be an 8k announcing an increase to the AS followed by an S-1 registration statement for a new offering. Those will cause a market correction to the share price in a downward direction.

Maybe the new CEO will have some bright idea like mailing out product catalogs like good ole Sears. This new fandangled online purchasing like Amazon is just a fad........
๐Ÿ‘๏ธ0
carusso carusso 4 weeks ago
Hereโ€™s to hoping things improve!
๐Ÿ‘๏ธ0
carusso carusso 4 weeks ago
Great to hear that. There is a big need for such products, if they really work and have high quality control standards.
๐Ÿ‘๏ธ0
PROPHET-of-PROFITS PROPHET-of-PROFITS 4 weeks ago
new ceo and board member have me interested
๐Ÿ‘๏ธ0
powerbattles powerbattles 4 weeks ago
Thank you. I already placed an order for the products. Loved these pills.
๐Ÿ‘๏ธ0
carusso carusso 4 weeks ago
There is a description and apparent ability to purchase this product at

www.pluripain.com

Otherwise they list this contact info:

(877) 252 โ€“ 8282

info@bioadaptives.com

๐Ÿ‘๏ธ0
Nezitic Nezitic 4 weeks ago
Some good soup?
๐Ÿ‘๏ธ0
JOHNNY-VEGAS JOHNNY-VEGAS 4 weeks ago
SOMETHING IS COOKING .
I could smell it.😂
๐Ÿ‘๏ธ0
DK11 DK11 4 weeks ago
let's hope we get some kind of a recovery, will see
๐Ÿ‘๏ธ0
cashmagnet cashmagnet 4 weeks ago
Those of us who've lost a metric ton of money here haven't forgotten...Sigh...
๐Ÿ‘๏ธ0
mars2063 mars2063 4 weeks ago
It's dead
๐Ÿ‘๏ธ0
powerbattles powerbattles 4 weeks ago
Thank you. Appreciated.
๐Ÿ‘๏ธ0
Ribo Ribo 4 weeks ago
https://flyingcbar.myshopify.com/collections/all
๐Ÿ‘๏ธ0
powerbattles powerbattles 4 weeks ago
They developed a new website. I can no longer purchase this product called PluriPain. Does anyone here know where I can find this amazing PluriPain?
๐Ÿ‘๏ธ0
mars2063 mars2063 1 month ago
????? Dilution??? As 2 bill?
Fake society!
๐Ÿ‘๏ธ0
mars2063 mars2063 1 month ago
News ?????????
๐Ÿ‘๏ธ0
DK11 DK11 1 month ago
That would be nice, I was just expecting this New Management to do a little more. At least say something.
๐Ÿ‘๏ธ0
WorkinGreen WorkinGreen 1 month ago
Good. Havnโ€™t forgot about it enough to let me get my damn .0001s yet tho
๐Ÿ‘๏ธ0
DK11 DK11 1 month ago
wow 39 volume' looks like everyone has forgot about this failure
๐Ÿ‘๏ธ0
carusso carusso 1 month ago
Hear, hear!
๐Ÿ‘๏ธ0
awesomed007 awesomed007 1 month ago
Good, this stock needs some serious help. Investors not happy about stockโ€™s performance, straight up awful.
๐Ÿ‘๏ธ0
unvctrader9m unvctrader9m 2 months ago
Either this guy is out of his mind to join BDPT or they have something really special we donโ€™t know about it yet!
Wait game!
At least no dilution for a while now
๐Ÿ‘๏ธ0
MC10459 MC10459 2 months ago
https://menafn.com/1108279173/Investornewsbreaks-Bioadaptives-Inc-BDPT-Appoints-Car-Rental-Industry-Veteran-To-Its-Board-Of-Directors
๐Ÿ‘๏ธ0
DK11 DK11 2 months ago
Hopefully it only gets better from now on.
๐Ÿ‘๏ธ0
stervc stervc 2 months ago
BDPT Welcomes Gimhana Dissanayake to Its Board of Directors...

This is more solid news for BDPT as a guy of this caliber would not be joining this team for something small in my opinion:

https://www.otcmarkets.com/stock/BDPT/news/story?e&id=2876656
BioAdaptives, Inc. Welcomes Gimhana Dissanayake to Its Board of Directors.

We are confident that Gimhanaโ€™s leadership will significantly enrich our boardโ€™s talent and expertise, propelling us to new heights.

LAS VEGAS, May 30, 2024 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT), a leader in the health and wellness sector, today announces the appointment of Gimhana Dissanayake to its Board of Directors. Gimhana, who currently serves as the vice president of operational sales for North America at The Hertz Corporation (NYSE: HTZ), brings over two decades of comprehensive experience and a proven track record of strategic growth and operational excellence to BioAdaptives.

With an illustrious career that has spanned various leadership roles at Hertz, Gimhana is renowned for his strategic vision and leadership acumen. He has been instrumental in advancing the Hertz, Dollar and Thrifty brands, significantly enhancing their market presence and competitive edge. As the senior director of strategic partnerships, he spearheaded initiatives that fostered key alliances with Fortune 500 companies and drove substantial growth across 10 revenue verticals for North America. His efforts earned him the nickname โ€œFounder of Canadaโ€ within Hertz, a testament to his successful expansion of the companyโ€™s market share in the region. His strategic prowess is a valuable asset that will undoubtedly benefit BioAdaptives.

Gimhana's educational background and extensive professional experience make him an invaluable addition to the BioAdaptives board. He holds an undergraduate degree from Oklahoma State University and an MBA from California State University, Sacramento. In addition, he has completed advanced executive education at Cornell University and the Wharton School of Business. This rich academic and professional foundation equips him with the knowledge and skills necessary to significantly contribute to Bioadaptive's growth and success.

โ€œWe are delighted to welcome Gimhana to our Board of Directors,โ€ said Jim Keener, chairman of the board at BioAdaptives. โ€œHis exceptional contributions to the car rental industry and his strategic insight are precisely what BioAdaptives needs as we continue to innovate and expand our reach in the wellness sector. We are confident that Gimhanaโ€™s leadership will significantly enrich our boardโ€™s talent and expertise, propelling us to new heights.โ€

About BioAdaptives

BioAdaptives, Inc. develops and distributes natural herbal-based products that improve health and wellness for humans and animals, with an emphasis on optimizing pain relief, antiviral activity, and immune system defense; stress resistance; endurance; recovery from injury, illness, and exercise; and anti-aging properties. Our current dietary supplement formulations are carefully selected from the best sources worldwide, and proprietary methods are utilized to enhance the bioavailability of nutrients. Our products for horses and dogs have also demonstrated increased general health, competitive performance enhancement, rejuvenation effects, pain relief and improved appearance.

BioAdaptives' common shares trade in the OTC market under the symbol BDPT. None of the statements about our products have been approved by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Additional information can be found at www.shopbioadaptives.com or in our SEC filings.

Safe Harbor Statement

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, trends, analysis, and other information contained in this press release, including words such as "anticipate," "believe," "plan," "estimate," "expect," "intend," and other similar expressions of opinion, constitute forward-looking statements. Any such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from any future results described within the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the press release date, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date after the date of this press release.

Contact

Investor Relations
BioAdaptives, Inc.
(702) 659-8829
info@bioadaptives.com

Corporate Communications:

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

v/r
Sterling
👍️ 1 💩 1 🤡 1
MC10459 MC10459 2 months ago
https://www.investorwire.com/newsarticle/?qmstory=5266682648393905
๐Ÿ‘๏ธ0
MC10459 MC10459 2 months ago
https://www.streetinsider.com/dr/news.php?id=23300472&gfv=1
๐Ÿ‘๏ธ0
Dark Roast Dark Roast 2 months ago
lol. You mean the new story to lure the sheep in? Hahaha.
๐Ÿ‘๏ธ0
mars2063 mars2063 2 months ago
Bad bad bad 👎👎👎
๐Ÿ‘๏ธ0
DK11 DK11 2 months ago
More possible now then before
๐Ÿ‘๏ธ0
carusso carusso 2 months ago
Great. Can we get out of trips now?
๐Ÿ‘๏ธ0
Ribo Ribo 2 months ago
8k, James Keener as new CEO.
https://ih.advfn.com/stock-market/USOTC/bioadaptives-pk-BDPT/stock-news/93904851/form-8-k-current-report
๐Ÿ‘๏ธ0
DK11 DK11 2 months ago
This new CEO James Keener, hopefully can bring in some institutional investors and more Capital possibly through his connections. will see
๐Ÿ‘๏ธ0
Ribo Ribo 2 months ago
James Keener, recently appointed as the Chief Executive Officer of BioAdaptives, Inc., BDPT, brings a wealth of experience spanning nearly three decades. His entrepreneurial journey has traversed various sectors, including real estate, agricultural science, hospitality, construction, and maintenance systems, equipping him with a multifaceted perspective on business and innovation.

As a dynamic leader, Keener has earned a sterling reputation for cultivating a culture of productivity and enthusiasm among stakeholders, consistently delivering exceptional outcomes. He is particularly noted for his role as a turnaround specialist, adept at transforming underperforming ventures into profitable enterprises.

Before his tenure at BioAdaptives, Keener honed his strategic acumen first as a consultant and subsequently as the CEO of a family office investment fund. There, he skillfully managed diversified holdings in real estate, business investment, agriculture, retail, and internet marketing, proving his ability to oversee and expand complex portfolios effectively.

Keener's entrepreneurial prowess is best demonstrated by the specialized construction and maintenance company he founded, which, under his guidance, achieved remarkable growth. It was acknowledged as the fastest-growing company in all sectors across the Hawaiian islands in 2019 and continued its upward trajectory into 2020.

In his new role at BioAdaptives, Keener is poised to leverage his extensive experience in operational transformation to drive innovation and growth within the advanced nutrition and wellness solutions sector. His leadership comes at a crucial juncture for the company, which is on the brink of expanding its influence in the market of high-quality wellness and nutritional products, catering to a diverse range of consumer needs, including both human and animal health.

Under Keenerโ€™s guidance, BioAdaptives is set to redefine industry standards by elevating the research and development of nutritional solutions, thereby enhancing health and wellness globally. He officially assumed his role as CEO on May 21, 2024, and is unwavering in his commitment to expanding BioAdaptives' product offerings and market presence, while nurturing a team of exceptional talent.
https://www.shopbioadaptives.com/pages/investors
๐Ÿ‘๏ธ0
pinkslipjunkie pinkslipjunkie 2 months ago
Oh Oh...the scientist bailed.
๐Ÿ‘๏ธ0
Penny2Dime Penny2Dime 2 months ago
Day1!
๐Ÿ‘๏ธ0
DK11 DK11 2 months ago
This is good news that finally got rid of the old ducks.
๐Ÿ‘๏ธ0
WorkinGreen WorkinGreen 2 months ago
โ€œBioAdaptives, Inc. Appoints James Keener as New CEO to Lead Strategic Growth Initiatives

LAS VEGAS, NV - (NewMediaWire) - May 21, 2024 - BioAdaptives, Inc. (OTC: BDPT), a pioneer in advanced nutrition and wellness solutions, announced a significant addition to its Executive Team today. James Keener has been appointed the new CEO and will play a pivotal role in driving the company's strategic initiatives and fostering continued growth.

BioAdaptives announced today that James Keener, a seasoned marketing and turnaround innovative executive, had taken over as the new Chief Executive Officer and Chairman of the Board of the Company. Among his various endeavors, Mr Keener brings a wealth of experience and expertise to BioAdaptives. He has led a specialized construction and maintenance company to become the fastest-growing company in Hawaii for 2019/2020, a testament to his ability to drive growth. He has also successfully turned around a private investment company with diverse real estate, agriculture, retail, and Internet marketing holdings, demonstrating his strategic thinking and leadership. Mr. Keener's past successes instill optimism for BioAdaptives' future and underline his potential to drive the Company's growth.

Dr. Edward Jacobs, former CEO, said, "After personally devoting a decade to discovery and product development at BioAdaptives, I look forward to the new leadership of James Keener, which will focus more on sales and distribution. I understand that Mr. Keener enjoys a reputation as an innovative Marketer with expertise in helping companies increase Revenues and Profits." Outgoing President Robert Ellis adds, "The company is extremely happy in anticipation of Mr. Keener's strong and varied executive management leadership and innovation, especially in the areas of marketing and sales development and expansion. We wish the New Management Team well in achieving their goals and objectives for BioAdaptives."

"BioAdaptives extends its good wishes and appreciation to both Dr. Jacobs and Mr. Ellis for their many years of dedicated work. The Company fully appreciates the personal and family demands that required their new focus," said Mr. James Keener. "I am honored to be part of BioAdaptives and am excited to get to work applying my extensive experience in operational transformation to another exciting sector."

Mr.Keener adds, "I am committed to leveraging our core strengths and unlocking new opportunities for innovation and growth, aligning with our mission to improve health and wellness through high-quality, research-driven nutritional products; together, we will continue to enhance our product offerings and expand our market footprint."

$BDPT
๐Ÿ‘๏ธ0
Rainer Rainer 2 months ago
https://www.otcmarkets.com/stock/BDPT/news/story?e&id=2866848
๐Ÿ‘๏ธ0
carusso carusso 2 months ago
Hope so, too!
๐Ÿ‘๏ธ0
stervc stervc 2 months ago
carusso...

I'm just holding and hoping that the CEO given his qualifications would not be here keeping BDPT current with it SEC filing if he had no plan to eventually move forward.

v/r
Sterling
💩 1 🤡 1
carusso carusso 2 months ago
Ok, thx
๐Ÿ‘๏ธ0
pinkslipjunkie pinkslipjunkie 2 months ago
I don't know what will happen here...sorry I can't give you a better insight
๐Ÿ‘๏ธ0
carusso carusso 2 months ago
Care to share your views on the future of this company?
๐Ÿ‘๏ธ0
carusso carusso 2 months ago
Thanks for posting thatโ€ฆ

Does this still have a detectable pulse?

๐Ÿ‘๏ธ0
DK11 DK11 2 months ago
Hopefully INTHEKNOW1 got rid of all his shares coming to an end now.
๐Ÿ‘๏ธ0